Paragraph (3) of new Article 25b provides that ESMA shall carry out its assessment of the resilience of recognised CCPs to adverse market conditions in accordance with the common methodologies established in Article 32(2) of the ESMA Regulation.
Odstavek (3) novega člena 25b določa, da mora ESMA svojo oceno odpornosti priznane CNS na neugodne tržne pogoje izvesti v skladu s skupnimi metodologijami, določenimi v členu 32(2) uredbe o ESMA.